Skip to main content

Advertisement

SpringerLink
Log in

The Neuropsychiatric and Neuropsychological Features of Chronic Fatigue Syndrome: Revisiting the Enigma

  • Complex Medical-Psychiatric Issues (MB Riba, Section Editor)
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

The aim of this article is to provide a comprehensive and updated review of the key neuropsychiatric and neuropsychological complaints associated with chronic fatigue syndrome (CFS). Neuropsychiatric and neuropsychological difficulties are common in CFS and are linked primarily to disorders of mood, affect and behaviour. The neuropsychiatric complaint most frequently encountered amongst CFS patients is depression and in particular major depressive disorder (MDD). Despite decades of research, the precise aetiological relationship between CFS and MDD remains poorly understood. This has resulted in the development of a number of interesting and polarised hypotheses regarding the aetiological nature of CFS. Recent scientific advances have however begun to unravel a number of interesting inflammatory and immunological explanations that suggest CFS and MDD are distinct yet interrelated conditions. The possibility that the overlap between CFS and MDD might be explained in terms of shared oxidative and nitrosative (IO&NS) pathways is an area of intense research interest and is reviewed in detail in this article. The overlap between CFS and MDD is further differentiated by variations in HPA axis activity between the two disorders. Important immunological differences between MDD and CFS are also reviewed with particular emphasis on antiviral RNase L pathways in CFS. In addition to the presence of neuropsychiatric complaints, CFS is also associated with neuropsychological symptoms such as impaired attention, memory and reaction time. The key neuropsychological problems reported by CFS patients are also included in the review in an effort to understand the significance of cognitive impairment in CFS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. •• Christley Y, Duffy T, Martin CR. A review of the definitional criteria for chronic fatigue syndrome. J Eval Clin Pract. 2012;18:25–31. This important paper highlights longstanding inconsistencies and irregularities in definitional criteria regarding CFS and the implications that these enduring inconsistencies may have on developing convincing aetiological accounts.

    Article  PubMed  Google Scholar 

  2. Jason LA, Taylor R, Wagner L, Holden J, Ferrari JR, Plioplys AV, et al. Estimating rates of chronic fatigue syndrome from a community-based sample: a pilot study. Am J Community Psychol. 1995;23:557–68.

    Article  PubMed  CAS  Google Scholar 

  3. Jason LA, Porter N, Hunnell J, Brown A, Rademaker A, Richman JA. A natural history study of chronic fatigue syndrome. Rehabil Psychol. 2011;56:32–42.

    Article  PubMed  Google Scholar 

  4. Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med. 1996;101:364–70.

    Article  PubMed  CAS  Google Scholar 

  5. Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. Med Care. 1996;34:924–30.

    Article  PubMed  CAS  Google Scholar 

  6. McCrone P, Darbishire L, Ridsdale L, Seed P. The economic cost of chronic fatigue and chronic fatigue syndrome in UK primary care. Psychol Med. 2003;33:253–61.

    Article  PubMed  CAS  Google Scholar 

  7. Ross SD, Estok RP, Frame D, Stone LR, Ludensky V, Levine CB. Disability and chronic fatigue syndrome: a focus on function. Arch Intern Med. 2004;164:1098–107.

    Article  PubMed  Google Scholar 

  8. Manu P, Affleck G, Tennen H, Morse PA, Escobar JI. Hypochondriasis influences quality-of-life outcomes in patients with chronic fatigue. Psychother Psychosom. 1996;65:76–81.

    Article  PubMed  CAS  Google Scholar 

  9. Fuller-Thomson E, Nimigon J. Factors associated with depression among individuals with chronic fatigue syndrome: findings from a nationally representative survey. Fam Pract. 2008;25:414–22.

    Article  PubMed  Google Scholar 

  10. Iwase M, Okajima R, Takahashi T, Mogami N, Kusaka H, Takeda M, et al. Psychiatric treatment and assessment of chronic fatigue syndrome in Japan. In: Watanabe Y, Evengård B, Natelson BH, Jason LA, Kuratsune H, editors. Fatigue science for human health. Springer: London; 2008. p. 103–19.

    Google Scholar 

  11. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting. Am J Psychiatr. 1996;153:1050–9.

    PubMed  CAS  Google Scholar 

  12. Manu P, Lane TJ, Matthews DA. Chronic fatigue and chronic fatigue syndrome: clinical epidemiology and aetiological classification. CIBA Found Symp. 1993;173:23–31.

    PubMed  CAS  Google Scholar 

  13. Offenbaecher M, Glatzeder K, Ackenheil M. Self-reported depression, familial history of depression and fibromyalgia (FM), and psychological distress in patients with FM. Z Rheumatol. 1998;57 Suppl 2:94–6.

    Article  PubMed  Google Scholar 

  14. Buchwald D, Pearlman T, Kith P, Katon W, Schmaling K. Screening for psychiatric disorders in chronic fatigue and chronic fatigue syndrome. J Psychosom Res. 1997;42:87–94.

    Article  PubMed  CAS  Google Scholar 

  15. Van Houdenhove B, Kempke S, Luyten P. Psychiatric aspects of chronic fatigue syndrome and fibromyalgia. Curr Psychiatr Rep. 2010;12:208–14.

    Article  Google Scholar 

  16. Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. 2012;36:764–85.

    Article  PubMed  CAS  Google Scholar 

  17. Axe EK, Satz P, Rasgon NL, Fawzy FI. Major depressive disorder in chronic fatigue syndrome: a CDC Surveillance Study. J Chron Fatigue Syndr. 2004;12:7–23.

    Article  Google Scholar 

  18. Roy-Byrne P, Afari N, Ashton S, Fischer M, Goldberg J, Buchwald D. Chronic fatigue and anxiety/depression: a twin study. Br J Psychiatry. 2002;180:29–34.

    Article  PubMed  Google Scholar 

  19. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: A prospective primary care study. Am J Public Health. 1997;87:1449–55.

    Article  PubMed  CAS  Google Scholar 

  20. Nater UM, Jones JF, Lin JM, Maloney E, Reeves WC, Heim C. Personality features and personality disorders in chronic fatigue syndrome: a population-based study. Psychother Psychosom. 2010;79:312–8.

    Article  PubMed  Google Scholar 

  21. Taylor RR, Jason LA, Jahn SC. Chronic fatigue and sociodemographic characteristics as predictors of psychiatric disorders in a community-based sample. Psychosom Med. 2003;65:896–901.

    Article  PubMed  Google Scholar 

  22. Murrough JW, Mao X, Collins KA, Kelly C, Andrade G, Nestadt P, et al. Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder. NMR In Biomed. 2010;23:643–50.

    Article  CAS  Google Scholar 

  23. Zimmermann TT, Sattel HH. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med. 2003;65:528.

    Article  PubMed  Google Scholar 

  24. Duffy FH, McAnulty GB, McCreary MC, Cuchural GJ, Komaroff AL. EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients-A case control study. Bmc Neurol. 2011; 11.

  25. Johnson SK, DeLuca J, Natelson BH. Depression in fatiguing illness: comparing patients with chronic fatigue syndrome, multiple sclerosis and depression. J Affect Disord. 1996;39:21–30.

    Article  PubMed  CAS  Google Scholar 

  26. Powell R, Dolan R, Wessely S. Attributions and self-esteem in depression and chronic fatigue syndromes. J Psychosom Res. 1990;34:665–73.

    Article  PubMed  CAS  Google Scholar 

  27. Hawk C, Jason LA, Torres-Harding S. Differential diagnosis of chronic fatigue syndrome and major depressive disorder. Int J Behav Med. 2006;13:244–51.

    Article  PubMed  Google Scholar 

  28. Jason LA, Richman JA, Friedberg F, Wagner L, Taylor R, Jordan KM. Politics, science, and the emergence of a new disease. The case of chronic fatigue syndrome. Am Psychol. 1997;52:973–83.

    Article  PubMed  CAS  Google Scholar 

  29. Silver A, Haeney M, Vijayadurai P, Wilks D, Pattrick M, Main CJ. The role of fear of physical movement and activity in chronic fatigue syndrome. J Psychosom Res. 2002;52:485–93.

    Article  PubMed  CAS  Google Scholar 

  30. Maes M, Twisk FNM. Treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a multisystem disease, should target the pathophysiological aberrations (inflammatory and oxidative and nitrosative stress pathways), not the psychosocial “barriers” for a new equilibrium. Patient Educ Couns. 2010;80:148–9.

    Article  PubMed  Google Scholar 

  31. Maes M, Mihaylova I, Leunis JC. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol Lett. 2007;28:861–7.

    PubMed  Google Scholar 

  32. Roberts AD, Papadopoulos AS, Wessely S, Chalder T, Cleare AJ. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. J Affect Disord. 2009;115:280–6.

    Article  PubMed  CAS  Google Scholar 

  33. Cleare A. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev. 2003;24:236–52.

    PubMed  CAS  Google Scholar 

  34. Maes M, Twisk FNM. Chronic fatigue syndrome: Harvey and Wessely’s (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. Bmc Medicine, 2010; 8.

  35. Hinkelmann K, Moritz S, Botzenhardt J, Muhtz C, Wiedemann K, Kellner M, Otte C. Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: A longitudinal study. Psychoneuroendocrinology, 2011.

  36. Hinkelmann K, Moritz S, Botzenhardt J, Riedesel K, Wiedemann K, Kellner M, et al. Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry. 2009;66:879–85.

    Article  PubMed  CAS  Google Scholar 

  37. Gomez RG, Posener JA, Keller J, DeBattista C, Solvason B, Schatzberg AF. Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function. Psychoneuroendocrinology. 2009;34:1012–8.

    Article  PubMed  CAS  Google Scholar 

  38. Jerjes W, Taylor N, Wood P, Cleare A. Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome. Psychoneuroendocrinology. 2007;32:192–8.

    Article  PubMed  CAS  Google Scholar 

  39. Nater UM, Youngblood LS, Jones JF, Unger ER, Miller AH, Reeves WC, et al. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med. 2008;70:298–305.

    Article  PubMed  CAS  Google Scholar 

  40. Nater UM, Maloney E, Boneva RS, Gurbaxani BM, Lin JM, Jones JF, et al. Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls. J Clin Endocrinol Metab. 2008;93:703–9.

    Article  PubMed  CAS  Google Scholar 

  41. Turan T, Izgi HB, Ozsoy S, Tanrıverdi F, Basturk M, Asdemir A, et al. The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome. Psychiatr Investig. 2009;6:204–10.

    Article  CAS  Google Scholar 

  42. Parker LN, Levin ER, Lifrak ET. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab. 1985;60:947–52.

    Article  PubMed  CAS  Google Scholar 

  43. Scott LV, Svec F, Dinan T. A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects. Psychiatr Res. 2000;97:21–8.

    Article  CAS  Google Scholar 

  44. Himmel PB, Seligman TM. A pilot study employing Dehydroepiandrosterone (DHEA) in the treatment of chronic fatigue syndrome. J Clin Rheumatol. 1999;5:56–9.

    Article  PubMed  CAS  Google Scholar 

  45. Liang SL, Quirk D, Zhou A. RNase L: its biological roles and regulation. IUBMB Life. 2006;58:508–14.

    Article  PubMed  CAS  Google Scholar 

  46. Nijs J, De Meirleir K. Impairments of the 2-5A synthetase/RNase L pathway in chronic fatigue syndrome. In Vivo. 2005;19:1013–21.

    PubMed  CAS  Google Scholar 

  47. Suhadolnik RJ, Peterson DL, Reichenbach NL, Roen G, Metzger M, McCahan J, et al. Clinical and biochemical characteristics differentiating chronic fatigue syndrome from major depression and healthy control populations: relation to dysfunction in the RNase L pathway. J Chron Fatigue Syndr. 2004;12:5–35.

    Article  Google Scholar 

  48. De Meirleir K, Bisbal C, Campine I, De Becker P, Salehzada T, Demettre E, et al. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med. 2000;108:99–105.

    Article  PubMed  Google Scholar 

  49. Hickie I, Lloyd A, Wakefield D, Parker G. The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry. 1990;156:534–40.

    Article  PubMed  CAS  Google Scholar 

  50. Pepper CM, Krupp LB, Friedberg F, Doscher C, Coyle PK. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatr Clin Neurosci. 1993;5:200–5.

    CAS  Google Scholar 

  51. Moss-Morris R, Petrie KJ. Discriminating between chronic fatigue syndrome and depression: a cognitive analysis. Psychol Med. 2001;31:469–79.

    Article  PubMed  CAS  Google Scholar 

  52. Somers JM, Goldner EM, Waraich P, Hsu L. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatr Rev Can Psychiatr. 2006;51:100–13.

    Google Scholar 

  53. Stein DJ, Ruscio AM, Lee S, Petukhova M, Alonso J, Andrade LH, et al. Subtyping social anxiety disorder in developed and developing countries. Depress Anxiety. 2010;27:390–403.

    Article  PubMed  Google Scholar 

  54. Kessler RC, Keller MB, Wittchen HU. The epidemiology of generalized anxiety disorder. Psychiatr Clin North Am. 2001;24:19–39.

    Article  PubMed  CAS  Google Scholar 

  55. Fischler B, Dendale P, Michiels V, Cluydts R, Kaufman L, De Meirleir K. Physical fatigability and exercise capacity in chronic fatigue syndrome: association with disability, somatization and psychopathology. J Psychosom Res. 1997;42:369–78.

    Article  PubMed  CAS  Google Scholar 

  56. Nutt DJ. Neurobiological mechanisms in generalized anxiety disorder. J Clin Psychiatr. 2001;62 Suppl 11:22–7. discussion 28.

    CAS  Google Scholar 

  57. Lipowski ZJ. Somatization: the concept and its clinical application. Am J Psychiatr. 1988;145:1358–68.

    PubMed  CAS  Google Scholar 

  58. Kirmayer LJ, Robbins JM, Paris J. Somatoform disorders: personality and the social matrix of somatic distress. J Abnorm Psychol. 1994;103:125–36.

    Article  PubMed  CAS  Google Scholar 

  59. Abbey SE. Somatization, illness attribution and the sociocultural psychiatry of chronic fatigue syndrome. CIBA Found Symp. 1993;173:238–52. discussion 252–61.

    PubMed  CAS  Google Scholar 

  60. Johnson SK, DeLuca J, Natelson BH. Assessing somatization disorder in the chronic fatigue syndrome. Psychosom Med. 1996;58:50–7.

    PubMed  CAS  Google Scholar 

  61. Manu P, Lane TJ, Matthews DA, Escobar JI. Screening for somatization disorder in patients with chronic fatigue. Gen Hosp Psychiatr. 1989;11:294–7.

    Article  CAS  Google Scholar 

  62. Demitrack MA. Neuroendocrine research strategies in chronic fatigue syndrome. In: Goodnick PJ, Klimas NG, editors. Chronic fatigue and related immune deficiency syndromes. Washington: American Psychiatric Press; 1993. p. 45–66.

    Google Scholar 

  63. Katon WJ, Walker EA. The relationship of chronic fatigue to psychiatric illness in community, primary care and tertiary care samples. CIBA Found Symp. 1993;173:193–204. discussion 204–11.

    PubMed  CAS  Google Scholar 

  64. Katon W, Russo J. Chronic fatigue syndrome criteria. A critique of the requirement for multiple physical complaints. Arch Intern Med. 1992;152:1604–9.

    Article  PubMed  CAS  Google Scholar 

  65. Johnson SK, DeLuca J, Natelson BH. Personality dimensions in the chronic fatigue syndrome: a comparison with multiple sclerosis and depression. J Psychiatr Res. 1996;30:9–20.

    Article  PubMed  CAS  Google Scholar 

  66. Ciccone DS, Busichio K, Vickroy M, Natelson BH. Psychiatric morbidity in the chronic fatigue syndrome: Are patients with personality disorder more physically impaired? J Psychosom Res. 2003;54:445–52.

    Article  PubMed  Google Scholar 

  67. Moran P, Coffey C, Mann A, Carlin JB, Patton GC. Dimensional characteristics of DSM-IV personality disorders in a large epidemiological sample. Acta Psychiatr Scand. 2006;113:233–6.

    Article  PubMed  CAS  Google Scholar 

  68. Glass JM. Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: new trends and future directions. Curr Rheumatol Rep. 2006;8:425–9.

    Article  PubMed  Google Scholar 

  69. Michiels V, Cluydts R. Neuropsychological functioning in chronic fatigue syndrome: a review. Acta Psychiatr Scand. 2001;103:84–93.

    Article  PubMed  CAS  Google Scholar 

  70. Caseras X, Mataix-Cols D, Giampietro V, Rimes KA, Brammer M, Zelaya F, et al. Probing the working memory system in chronic fatigue syndrome: a functional magnetic resonance imaging study using the n-back task. Psychosom Med. 2006;68:947–55.

    Article  PubMed  Google Scholar 

  71. Claypoole KH, Noonan C, Mahurin RK, Goldberg J, Erickson T, Buchwald D. A twin study of cognitive function in chronic fatigue syndrome: The effects of sudden illness onset. Neuropsychology. 2007;21:507–13.

    Article  PubMed  Google Scholar 

  72. Mahurin RK, Claypoole KH, Goldberg JH, Arguelles L, Ashton S, Buchwald D. Cognitive processing in monozygotic twins discordant for chronic fatigue syndrome. Neuropsychology. 2004;18:232–9.

    Article  PubMed  Google Scholar 

  73. Deluca J, Christodoulou C, Diamond BJ, Rosenstein ED, Kramer N, Natelson BH. Working memory deficits in chronic fatigue syndrome: differentiating between speed and accuracy of information processing. J Int Neuropsychol Soc. 2004;10:101–9.

    Article  PubMed  Google Scholar 

  74. Chiaravalloti ND, Christodoulou C, Demaree HA, DeLuca J. Differentiating simple versus complex processing speed: influence on new learning and memory performance. J Clin Exp Neuropsychol. 2003;25:489–501.

    Article  PubMed  Google Scholar 

  75. Crowe SF, Casey A. A neuropsychological study of the chronic fatigue syndrome: support for a deficit in memory function independent of depression. Aust Psychol. 1999;34:70–5.

    Article  Google Scholar 

  76. Fiedler N, Kipen HM, DeLuca J, Kelly-McNeil K, Natelson B. A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med. 1996;58:38–49.

    PubMed  CAS  Google Scholar 

  77. Tiersky LA, Johnson SK, Lange G, Natelson BH, DeLuca J. Neuropsychology of chronic fatigue syndrome: a critical review. J Clin Exp Neuropsychol. 1997;19:560–86.

    Article  PubMed  CAS  Google Scholar 

  78. Cockshell S, Mathias J. Cognitive functioning in chronic fatigue syndrome: a meta-analysis. Psychol Med. 2010;40:1253–67.

    Article  PubMed  CAS  Google Scholar 

  79. Majer M, Welberg LA, Capuron L, Miller AH, Pagnoni G, Reeves WC. Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study. Psychosom Med. 2008;70:829–36.

    Article  PubMed  Google Scholar 

  80. Tiersky LA, Matheis RJ, Deluca J, Lange G, Natelson BH. Functional status, neuropsychological functioning, and mood in chronic fatigue syndrome (CFS): relationship to psychiatric disorder. J Nerv Ment Dis. 2003;191:324–31.

    PubMed  Google Scholar 

  81. •• Duffy FH, McAnulty GB, McCreary MC, Cuchural GJ, Komaroff AL. EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients—a case control study. BMC Neurol. 2011;11:82. This excellent paper highlights evidence of important and distinguising features of abnormal brain physiology suggesting temporal lobe involvement in CFS.

    Article  PubMed  Google Scholar 

  82. Wearden A, Appleby L. Cognitive performance and complaints of cognitive impairment in chronic fatigue syndrome (CFS). Psychol Med. 1997;27:81–90.

    Article  PubMed  CAS  Google Scholar 

  83. Lutgendorf SK, Antoni MH, Ironson G, Fletcher MA, Penedo F, Baum A, et al. Physical symptoms of chronic fatigue syndrome are exacerbated by the stress of Hurricane Andrew. Psychosom Med. 1995;57:310–23.

    PubMed  CAS  Google Scholar 

  84. Daly E, Komaroff AL, Bloomingdale K, Wilson S, Albert MS. Neuropsychological function in patients with chronic fatigue syndrome, multiple sclerosis, and depression. Appl Neuropsychol. 2001;8:12–22.

    Article  PubMed  CAS  Google Scholar 

  85. Capuron L, Welberg L, Heim C, Wagner D, Solomon L, Papanicolaou DA, et al. Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome. Neuropsychopharmacology. 2006;31:1777–84.

    Article  PubMed  Google Scholar 

Download references

Disclosure

Y. Christley declares that she has no conflict of interest.

T. Duffy declares that he has no conflict of interest.

I. P. Everall has received compensation for lectures including service on speakers’ bureaus from Abbot and AstraZeneca.

C. R. Martin declares that he has no conflict of interest.

Author information

Authors and Affiliations

  1. School of Health, Nursing and Midwifery, University of the West of Scotland, Ayr Campus, University Avenue, Ayr, KA8 0SX, UK

    Yvonne Christley, Tim Duffy & Colin R. Martin

  2. Department of Psychiatry, University of Melbourne, Level 1 North, Royal Melbourne Hospital, Melbourne, Australia

    Ian Paul Everall

  3. School of Health, Nursing and Midwifery, University of the West of Scotland, University Campus Ayr, Beech Grove, Scotland, UK, KA8 0SR

    Colin R. Martin

Authors
  1. Yvonne Christley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tim Duffy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ian Paul Everall
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Colin R. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Colin R. Martin.

Additional information

This article is part of the Topical Collection on Complex Medical-Psychiatric Issues

Rights and permissions

Reprints and permissions

About this article

Cite this article

Christley, Y., Duffy, T., Everall, I.P. et al. The Neuropsychiatric and Neuropsychological Features of Chronic Fatigue Syndrome: Revisiting the Enigma. Curr Psychiatry Rep 15, 353 (2013). https://doi.org/10.1007/s11920-013-0353-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11920-013-0353-8

Keywords

Search

Navigation